- Published at
- by gurufocus.com
positive
positive
Amedisys (AMED) Faces DOJ Hurdle in UnitedHealth Deal
Amedisys (AMED) faces DOJ scrutiny over divestiture amid UnitedHealth merger. Analysts predict a modest 5.61% upside, based on a $100.83 average target